Polyrizon Hits Key Breakthrough That Brings Its Nasal Spray Closer To 2026 Trials

Benzinga · 3d ago

Polyrizon Ltd. (NASDAQ:PLRZ) stock rose Tuesday, with a session volume of 70.8 million compared to the average volume of 178.92 thousand as per data from Benzinga Pro.

The biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform said it completed a major manufacturing upscaling milestone for its proprietary nasal-spray product platform.

During the upscaling process, Polyrizon and its manufacturing partner transitioned from small-batch laboratory production to a larger-scale, controlled manufacturing run designed to validate key parameters of PL-14 formulation.

Also Read: Polyrizon Stock Slides After Hours After 52% Surge On Tuesday: Why It Moved

The milestone demonstrates that the PL-14 formulation can be reliably produced at increased batch volumes while maintaining high-quality specifications.

The manufacturing process is set to support the clinical trial material (CTM) needed for Polyrizon’s clinical trial, which is expected to commence in 2026.

PL-14 is Polyrizon’s intranasal protective spray designed to create a fast-acting, moisturizing barrier inside the nasal cavity, helping to trap, isolate, and neutralize airborne allergens before they reach the mucosa.

Based on a proprietary bio-adhesive formulation developed by Polyrizon, PL-14 is engineered to provide extended protection and offers a non-pharmacological solution for allergy sufferers in environments with high allergen exposure.

How To Buy PLRZ Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange-traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in Polyrizon’s case, it is in the healthcare sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

PLRZ Price Action: Polyrizon shares were up 98.10% at $6.26 at the time of publication on Tuesday, according to Benzinga Pro data.

Read Next:

Image via Shutterstock